Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Biol Interact ; 396: 111029, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38703806

ABSTRACT

Arsenic exposure is connected with lung toxicity and is related to lung fibrotic changes. Idiopathic pulmonary fibrosis (IPF) is characterized by extracellular matrix (ECM) deposition. Various genetic mechanisms and environmental factors induce or exacerbate pulmonary fibrosis. Collagen synthesis induced by sodium arsenite (NaAsO2) is closely associated with IPF. Fibroblasts tend to fine-tune their metabolic networks to support their synthetic requirements in response to environmental stimuli. Alterations in metabolism have an influential role in the pathogenesis of IPF. However, it is unclear how arsenic affects the metabolism in IPF. The urea cycle (UC) is needed for collagen formation, which provides adequate levels of proline (Pro) for biosynthesis of collagen. Carbamoyl phosphate synthetase 1 (CPS1) converts the ammonia to carbamoyl phosphate, which controls the first reaction of the UC. We show that, in arsenite-exposed mice, high amounts of ammonia in the lung microenvironment promotes the expression levels of CPS1 and the Pro metabolism. Reduction of ammonia and CPS1 ablation inhibit collagen synthesis and ameliorate IPF phenotypes induced by arsenite. This work takes advantage of multi-omics data to enhance understanding of the underlying pathogenic mechanisms, the key molecules and the complicated cellular responses to this pollutant, which provide a target for the prevention of pulmonary fibrosis caused by arsenic.


Subject(s)
Ammonia , Arsenites , Carbamoyl-Phosphate Synthase (Ammonia) , Collagen , Mice, Inbred C57BL , Pulmonary Fibrosis , Urea , Animals , Arsenites/toxicity , Ammonia/metabolism , Collagen/metabolism , Mice , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/metabolism , Pulmonary Fibrosis/pathology , Carbamoyl-Phosphate Synthase (Ammonia)/metabolism , Urea/metabolism , Up-Regulation/drug effects , Lung/metabolism , Lung/pathology , Lung/drug effects , Male , Idiopathic Pulmonary Fibrosis/metabolism , Idiopathic Pulmonary Fibrosis/chemically induced , Idiopathic Pulmonary Fibrosis/pathology , Sodium Compounds
2.
Environ Pollut ; 349: 123913, 2024 May 15.
Article in English | MEDLINE | ID: mdl-38582189

ABSTRACT

Cigarette smoke (CS), the main source of indoor air pollution and the primary risk factor for respiratory diseases, contains chemicals that can perturb microbiota through antibiotic effects. Although smoking induces a disturbance of microbiota in the lower respiratory tract, whether and how it contributes to initiation or promotion of emphysema are not well clarified. Here, we demonstrated an aberrant microbiome in lung tissue of patients with smoking-related COPD. We found that Stenotrophomonas maltophilia (S. maltophilia) was expanded in lung tissue of patients with smoking-related COPD. We revealed that S. maltophilia drives PANoptosis in alveolar epithelial cells and represses formation of alveolar organoids through IRF1 (interferon regulatory factor 1). Mechanistically, IRF1 accelerated transcription of ZBP1 (Z-DNA Binding Protein 1) in S. maltophilia-infected alveolar epithelial cells. Elevated ZBP1 served as a component of the PANoptosome, which triggered PANoptosis in these cells. By using of alveolar organoids infected by S. maltophilia, we found that targeting of IRF1 mitigated S. maltophilia-induced injury of these organoids. Moreover, the expansion of S. maltophilia and the expression of IRF1 negatively correlated with the progression of emphysema. Thus, the present study provides insights into the mechanism of lung dysbiosis in smoking-related COPD, and presents a potential target for mitigation of COPD progression.


Subject(s)
Alveolar Epithelial Cells , Interferon Regulatory Factor-1 , Pulmonary Emphysema , Smoking , Stenotrophomonas maltophilia , Animals , Humans , Alveolar Epithelial Cells/metabolism , Alveolar Epithelial Cells/microbiology , Interferon Regulatory Factor-1/metabolism , Interferon Regulatory Factor-1/genetics , Lung/microbiology , Microbiota , Pulmonary Disease, Chronic Obstructive , Pulmonary Emphysema/metabolism , Pulmonary Emphysema/microbiology , Smoking/adverse effects
3.
Angew Chem Int Ed Engl ; 63(4): e202315691, 2024 Jan 22.
Article in English | MEDLINE | ID: mdl-38038694

ABSTRACT

Calixarenes are among the most useful and versatile macrocycles in supramolecular chemistry. The one thing that has not changed in the 80 years since their discovery, despite numerous derivatizations, is their fully organic, covalent scaffolds. Here, we report a new type of organic-inorganic hybrid "calixarenes" constructed by means of coordination-driven assembly. Replacing acetate ligands on the {SiW10 Cr2 (OAc)2 } clusters with 5-hydroxyisophthalates allows these 95° inorganic building blocks to be linked into bowl-shaped, hybrid "calix[n]arenes" (n=3, 4). With a large concave cavity, the metal-organic calix[4]arene can accommodate nanometer-sized polyoxoanions in an entropically driven process. The development of hybrid variants of calixarenes is expected to expand the scope of their physicochemical properties, guest/substrate binding, and applications on multiple fronts.

4.
Inorg Chem ; 62(38): 15340-15345, 2023 Sep 25.
Article in English | MEDLINE | ID: mdl-37695307

ABSTRACT

A coordination macrocycle composed of eight identical [PMo8O27]- ({PMo8}) clusters connected by both organic tetraphosphonates and inorganic phosphates, (C3N2H5)29(NH4)6H12[(PMo8O27)8(C10P4O12N2H20)4(PO4)4Cs(Mo4O10(H2O)4)] (C3N2H5+ = imidazolium), is presented here. The primary building block, {PMo8}, is a tetravacant Keggin-type phosphomolybdate that has never been observed before. The compound shows a high proton conductivity of 9.70 × 10-3 S cm-1 at 373 K and 98% relative humidity. Control experiments on an imidazolium-free sample demonstrate the critical role of the imidazolium counterions as mobile proton carriers. The contribution of imidazolium necessitates a high activation energy (Ea = 0.502 eV) for proton conduction via the vehicle mechanism.

5.
Cell Death Differ ; 30(5): 1293-1304, 2023 05.
Article in English | MEDLINE | ID: mdl-36828914

ABSTRACT

Epithelial cell damage-initiated chronic obstructive pulmonary disease (COPD) is implicated in regulated cell death (RCD) including ferroptosis triggered by complex gene-environment interactions. Our data showed that iron overload and ferroptosis are associated with COPD progression in COPD patients and in experimental COPD. Furthermore, we found that, in lung tissues of COPD patients, circSAV1 was associated with COPD progression by circRNA-seq screening. Knockdown of circSAV1 reversed cigarette smoke extract (CSE)-induced ferroptosis. Mechanistically, m6A-modified circSAV1 formed an RNA-protein ternary complex of circSAV1/YTHDF1/IREB2 to facilitate the translation of IREB2 mRNA. Elevated protein levels of IREB2 disrupted iron homeostasis, resulting in accumulation of a labile iron pool (LIP) and lipid peroxidation, which contribute to ferroptosis. Here we demonstrate, by use of an experimental COPD model induced by cigarette smoke (CS), that silencing of circSAV1 and the treatment with deferoxamine (DFO) blocked CS-induced ferroptosis of lung epithelial cells, which attenuated COPD progression in mice. Our results reveal that N6-methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2, indicating that circSAV1 is a mediator of ferroptosis and that circSAV1-dependent ferroptosis is a therapeutic target for COPD. In lung epithelial cell, m6A-modified circSAV1, via recruiting YTHDF1, induces the formation of a circSAV1/YTHDF1/IREB2 mRNA protein ternary complex, which promotes translation of IREB2 mRNA. Further, elevated IREB2 contributes to the accumulation of a labile iron pool (LIP) and lipid peroxidation, then triggers ferroptosis of lung epithelial cells. The ferroptosis of airway epithelial cells and alveolar epithelial cells induces airway remodeling and emphysema, respectively, which causes COPD.


Subject(s)
Ferroptosis , Pulmonary Disease, Chronic Obstructive , Animals , Mice , Iron/metabolism , Lung/metabolism , Pulmonary Disease, Chronic Obstructive/drug therapy , Pulmonary Disease, Chronic Obstructive/genetics , Pulmonary Disease, Chronic Obstructive/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...